• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (8)
    • Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    • Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration.
    • Changes in extracellular collagen matrix alter myocardial systolic performance.
    • Cardiac arrhythmia: current therapy.
    • Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.
    • See All 8 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.

Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood. 1994 Sep 15; 84(6):1931-41.

View in: PubMed

subject areas
  • Base Sequence
  • Bone Marrow
  • Cell Differentiation
  • Flow Cytometry
  • Gene Expression
  • Hematopoiesis
  • Humans
  • Interferon-alpha
  • Leukemia
  • Leukemia, Lymphoid
  • Leukemia, Myeloid
  • Molecular Sequence Data
  • Monocytes
  • Myelodysplastic Syndromes
  • Oncogene Proteins
  • Polymerase Chain Reaction
  • Proto-Oncogene Proteins
  • Receptor Protein-Tyrosine Kinases
  • RNA, Messenger
  • RNA-Directed DNA Polymerase
  • Tetradecanoylphorbol Acetate

authors with profiles
  • John P. O'Bryan